Navigation Links
Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
Date:2/29/2012

CAMBRIDGE, Mass., Feb. 29, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 at 8:40 a.m. ET at the Boston Marriott Copley Place, Massachusetts; the 24th Annual Roth Conference on March 12, 2012 at 4:00 p.m. PT at the Ritz Carlton Laguna Niguel, California; and the Barclays Capital Global Healthcare Conference on March 14, 2012 at 2:30 p.m. ET at the Loews Miami Hotel, Florida.

The live and archived webcasts of the company presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
2. Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference
3. Idenix to Host Conference Call Discussing Fourth Quarter and Year End 2011 Financial Results and Pipeline Update
4. Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184
5. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. Idenix Pharmaceuticals Prices Public Offering of Common Stock
7. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
9. Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
10. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
11. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... TAIPEI , 1. September 2015 ... Marksteins von 2.500 Mitarbeitern hat die SHL Group ... ein konstantes und rapides Wachstum auf dem ... Engagement, die Produktivität und das Management von SHL ... SHL ist weltweit führend in Design ...
(Date:9/1/2015)... Sept. 1, 2015 Pressure BioSciences, Inc. ... in the development and sale of broadly enabling, ... the worldwide life sciences industry, today announced the ... the Company,s PCT Platform could play a significant ... This role is based on PCT,s unique ability ...
(Date:9/1/2015)... VIEW, Calif. , Sept. 1, 2015 ... the cardiovascular image management market, Frost & ... the 2015 European Frost & Sullivan Award ... -based PMI has designed innovative and ... lines—which deliver precise and reproducible quantitative results ...
Breaking Medicine Technology:SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5
... Second generation,pyridopyrazine-urea derivative compound series show highly,selective ... , , QUBEC CITY, Canada, April,16, ... Nasdaq:,AEZS), a global, pure play biopharmaceutical company ... an abstract,outlining first in vitro data on ...
... Activity as Vascular Disrupting Agent and,Tubulin Inhibitor ... 2007—Myriad Genetics, Inc.,(NASDAQ: MYGN) (<a target="_blank" href=,"http://www.myriad.com/">www.myriad.com ... characterize the mode of action of its,investigational ... at the annual meeting of the American ...
Cached Medicine Technology:terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 4Myriad Genetics Presents Azixa's Mode of Action at AACR 2Myriad Genetics Presents Azixa's Mode of Action at AACR 3
(Date:9/1/2015)... Fairfax, VA (PRWEB) , ... September 01, 2015 ... ... the Mane Vendor “Hair Extension Vending Machine,” is still strongly maintaining her firm’s ... modern technology, and beauty tools. In her upcoming city-to-city tour, Ellis will be ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... Information Management has been granted continued accreditation based on a successfully completed ... “Achieving and maintaining this accreditation takes the involvement and dedication of each ...
(Date:9/1/2015)... ... 01, 2015 , ... With former IBMers among its founding members, Inmar has ... more than 35 years ago. A pilot program begun by the company in 2014 ... just those intent on pursuing careers in these fields. The program is now open ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Royal River Natural ... study that followed men and women for 19 years and found that, among those ... not take multivitamins. , The report is part of the September 2015 issue of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The ... and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of a collection ... same mission – to raise awareness of the FSH Society and further FSHD research. ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3
... Feb. 24 drugstore.com , inc. (Nasdaq: ... of health, beauty, vision, and pharmacy products, today ... be presenting at the upcoming Jefferies 5th Annual ... drugstore.com(TM) presentation will take place on Thursday, February ...
... 24 PolyRemedy, Inc., a,manufacturer of point-of-care robotic ... wound treatments, has hired Jeffrey S.,Jones to serve ... Jones, a,seasoned healthcare executive, joined the PolyRemedy management ... "With his experience in growing innovative medical device ...
... New guidelines suggest that men discuss use of medicines such ... News) -- Healthy men with no signs of prostate cancer ... drug that could further reduce their risk for the disease, ... Oncology and the American Urological Association have issued new guidelines ...
... danger, large study finds, , , TUESDAY, Feb. 24 (HealthDay News) ... that even moderate drinking raises risks for breast, liver and ... on the order of one alcoholic drink per day -- ... Naomi Allen, from the cancer epidemiology unit at the University ...
... would Lower the Standard of Care by Allowing ... Anesthesia to Maryland PatientsANNAPOLIS, Md., Feb. 24 ... members are Certified Registered Nurse Anesthetists (CRNAs), today ... House Bill 1161. These troubling bills would ...
... RIVER EDGE, N.J., Feb. 24 ... device company developing and marketing filtration products for ... reported that is has received initial responses from ... for dialysis devices. 510k Application for OLpur ...
Cached Medicine News:Health News:drugstore.com, inc. to Present at the Upcoming Jefferies 5th Annual Internet & Media Conference 2Health News:PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer 2Health News:Drugs May Help Healthy Men Lower Prostate Cancer Risk 2Health News:Drinking Raises Cancer Risk for Middle-Age Women 2Health News:Drinking Raises Cancer Risk for Middle-Age Women 3Health News:New Anesthesia Provider May Threaten Operating Room Safety 2Health News:New Anesthesia Provider May Threaten Operating Room Safety 3Health News:New Anesthesia Provider May Threaten Operating Room Safety 4Health News:Nephros Provides Update on 510k Applications 2Health News:Nephros Provides Update on 510k Applications 3Health News:Nephros Provides Update on 510k Applications 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: